Advagene Biopharma Co., Ltd.
About Advagene
Milestone
Management Team
Board of Directors
R&D PIPELINE
NEW DRUG PEPLINE
Intranasal Vaccines
Airway allergy immunotherapy
Covid-19-immunitytherapy
Other vaccine applications
News
News
Press Releases
Partnerships and Collaborators
Investors
Catalogs
公開資訊觀測站
繁體中文
English
简体中文
Contact Us
Home
News
News
The last subject of the Phase II clinical trial of the COVID-19 treatment in Taiwan completed the drug administration
The last subject of the Phase II clinical trial of the COVID-19 treatment in Taiwan completed the drug administration
The last subject of the Phase II clinical trial of the COVID-19 treatment in Taiwan completed the drug administration.
2023-04-16
Back
繁體中文
English
简体中文